Montelukast Prescribing at HARDWICKE HOUSE GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
2,906
Total Quantity
79.2K
NHS Cost
£3.8K
vs National Avg
+324.4%
HARDWICKE HOUSE GROUP PRACTICE prescribed 2,906 items of Montelukast over the last 12 months at a cost of £3,828 to the NHS. This is 324.4% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
252
Jul 2026
240
Jul 2026
240
Jul 2026
241
Jul 2026
228
Jul 2026
247
Jul 2026
238
Jul 2026
249
Jul 2026
249
Jul 2026
222
Jul 2026
255
Jul 2026
245
Prescribing Details
| Total Items | 2,906 |
|---|---|
| Total Quantity | 79,204 |
| Total NHS Cost | £3,828 |
| Presentations | 4 different forms |
| vs National Average | +324.4% |
Montelukast Prescribing Comparison
| This practice | 2,906 items |
|---|---|
| National average per practice | 685 items |
| Difference | +324.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.